Ginkgo biloba Extract 50 (GBE50) Exerts Antifibrotic and Antioxidant Effects on Pulmonary Fibrosis in Mice by Regulating Nrf2 and TGF-β1/Smad Pathways
- 16 November 2023
- journal article
- research article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 196 (8) , 4807-4822
Abstract
Background Pulmonary fibrosis (PF) is a progressive lung disorder with a poor prognosis. GBE50 is a new standardized Ginkgo biloba extract that has been widely used in cardiovascular diseases. However, the protective mechanism of GBE50 against PF remains to be elucidated. Methods C57BL/6J mice were treated with bleomycin (Bleo) to induce PF in the presence or absence of GBE50. Protein content in bronchoalveolar lavage fluid (BALF) and wet weight/dry weight ratio were examined for analysis of pulmonary edema. Hematoxylin-eosin staining and Masson trichrome staining were used for histopathological observation of murine lung tissues. Ashcroft score was used for semi-quantitation of lung fibrosis degree. RT-qPCR was utilized for assessing mRNA levels of pro-fibrotic mediators in lung tissues. TUNEL staining was implemented for cell apoptosis assessment. The levels of oxidative stress- and inflammation-related markers were evaluated by corresponding commercial assay kits. Western blotting was used to evaluate levels of nuclear factor erythroid 2-related factor 2 (Nrf2) signaling- and transforming growth factor (TGF)-β1/SMAD signaling-related proteins. Results GBE50 alleviated lung injury and severity of fibrosis, reduced collagen deposition and cell apoptosis in lung tissues, and suppressed inflammatory response and oxidative stress injury in Bleo-stimulated PF mice. GBE50 activated Nrf2 signaling pathway and inactivated TGF-β1/SMAD signaling pathway in the lungs of Bleo-induced PF mice. Inhibition of Nrf2 signaling reversed GBE50-mediated inactivation of TGF-β1/SMAD signaling and attenuation of inflammation and oxidative stress in Bleo-induced PF mice. Conclusion GBE50 protects against Bleo-induced PF in mice by mitigating fibrosis, inflammation and oxidative stress via Nrf2 and TGF-β1/SMAD signaling pathways.Keywords
Funding Information
- National Natural Science Foundation of China (81904111)
- Guangxi Natural Science Foundation (2020GXNSFBA297022)
This publication has 44 references indexed in Scilit:
- Oxidative stress and pulmonary fibrosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Glutathione synthesisBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathwayInternational Journal of Molecular Medicine, 2012
- Idiopathic pulmonary fibrosisThe Lancet, 2011
- Effect of Ginkgo Biloba Extract 50 on Immunity and Antioxidant Enzyme Activities in Ischemia Reperfusion RatsMolecules, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Exercise‐induced liver chemokine CXCL‐1 expression is linked to muscle‐derived interleukin‐6 expressionThe Journal of Physiology, 2011
- Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammationNature Nanotechnology, 2010
- Standardized Quantification of Pulmonary Fibrosis in Histological SamplesBioTechniques, 2008
- Inhibitory effect of Ginkgo biloba extract on human platelet aggregationPlatelets, 1999